Merck

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Merck and other ETFs, options, and stocks.

About MRK

Merck & Co., Inc. engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other.

CEO

Robert M. Davis

CEORobert M. Davis

Employees

68,000

Employees68,000

Headquarters

Kenilworth, New Jersey

HeadquartersKenilworth, New Jersey

Founded

1891

Founded1891

Employees

68,000

Employees68,000

MRK Key Statistics

Market cap

220.34B

Market cap220.34B

Price-Earnings ratio

13.28

Price-Earnings ratio13.28

Dividend yield

3.13

Dividend yield3.13

Average volume

8.54M

Average volume8.54M

High today

$87.61

High today$87.61

Low today

$86.26

Low today$86.26

Open price

$86.90

Open price$86.90

Volume

2.13M

Volume2.13M

52 Week high

$95.72

52 Week high$95.72

52 Week low

$71.50

52 Week low$71.50

MRK News

Benzinga 1d

Merck Inks Supply Deal With Sinopharm To Commercialize COVID-19 Pills In China

Merck & Co Inc (NYSE: MRK) signed a cooperation framework agreement in China for its COVID-19 antiviral pills, which were co-developed by Ridgeback Therapeutics...

Reuters 2d

Merck agrees to allow Sinopharm to sell molnupiravir COVID drug in China - Reuters

NEW YORK, Sept 28 (Reuters) - Drugmaker Merck & Co (MRK.N) said on Wednesday that it agreed to allow China's Sinopharm (1099.HK) to distribute and...

Simply Wall St 2d

With 75% ownership, Merck & Co., Inc. boasts of strong institutional backing

If you want to know who really controls Merck & Co., Inc. (NYSE:MRK), then you'll have to look at the makeup of its share registry. With 75% stake, institutions...

Analyst ratings

56%

of 25 ratings

Buy

56%

Hold

44%

Sell

MRK Earnings

$0.00

$0.71

$1.43

$2.14

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Estimated

— per share

Estimated— per share

Actual

Available Oct 27, Pre-Market

ActualAvailable Oct 27, Pre-Market

More MRK News

Simply Wall St 2d

We Ran A Stock Scan For Earnings Growth And Merck Passed With Ease

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even companies that have no revenue, no profit, an...

Simply Wall St 6d

Merck shareholders have earned a 11% CAGR over the last five years

If you buy and hold a stock for many years, you'd hope to be making a profit. Better yet, you'd like to see the share price move up more than the market average...

Investor's Business Daily 7d

With Seagen News Lacking, Is Merck Stock A Buy Or A Sell?

Merck stock jumped in September after winning a patent battle against Viatris (VTRS) and snagging approval in China for an AstraZeneca-partnered ovarian cancer...